JNJ

Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Pharmaceutical Business Review
Janssen
JNJ
EMA
Imbruvica
CLL
Flag link:
Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat?
Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat?
Yahoo/Zacks.com
JNJ
earnings
Flag link:
Johnson & Johnson Gets Punitive Damages in Risperdal Case Reduced to $6.8 Million
Johnson & Johnson Gets Punitive Damages in Risperdal Case Reduced to $6.8 Million
Motley Fool
JNJ
Risperdal
Flag link:
Why Johnson & Johnson Will Survive its Latest Litigation Wave
Why Johnson & Johnson Will Survive its Latest Litigation Wave
Motley Fool
JNJ
Risperdal
cancer
Flag link:
J&J, RoosterBio and Element Kick Off 2020 with Expansions
J&J, RoosterBio and Element Kick Off 2020 with Expansions
BioSpace
JNJ
Janssen
R&D
Rooster Bio
Element Biosciences
Flag link:
Janssen Expands Research & Development Presence with Major Investment in South San Francisco
Janssen Expands Research & Development Presence with Major Investment in South San Francisco
AP
JNJ
Janssen
R&D
San Francisco
Flag link:
J&J said to pay more than US$2M in rare talc settlement
J&J said to pay more than US$2M in rare talc settlement
Bloomberg
JNJ
Flag link:
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
Stat
Donald Trump
veterans
esketamine
major depression
Spravato
JNJ
Janssen
Flag link:
Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
Endpoints
uBiome
microbiome
M&A
Psomagen
JNJ
Pulmatrix
lung cancer
Flag link:
After midstage flop, Janssen says thanks but no thanks to Provention Bio drug
After midstage flop, Janssen says thanks but no thanks to Provention Bio drug
Fierce Biotech
Janssen
Provention Bio
Crohn’s disease
PRV-6527
JNJ
Flag link:
If You Invested $10,000 in Johnson & Johnson's IPO, This Is How Much Money You'd Have Now
If You Invested $10,000 in Johnson & Johnson's IPO, This Is How Much Money You'd Have Now
Motley Fool
JNJ
IPOs
pharma stocks
Flag link:
J&J Fires up the Surgical Robotics Market with New Verb Deal
J&J Fires up the Surgical Robotics Market with New Verb Deal
Medical Devices and Diagnostics Industry
JNJ
robotic surgery
devices
Verb Surgical
Verily
M&A
Flag link:
Pfizer, Astellas' Xtandi matches J&J's rival Erleada with new prostate cancer nod
Pfizer, Astellas' Xtandi matches J&J's rival Erleada with new prostate cancer nod
Fierce Pharma
Pfizer
Astellas
Xtandi
prostate cancer
JNJ
Erleada
FDA
Flag link:
Attorney misconduct allegations crop up in Johnson & Johnson, Gilead cases
Attorney misconduct allegations crop up in Johnson & Johnson, Gilead cases
Fierce Pharma
attorneys
JNJ
Gilead Sciences
Flag link:
Leukemia rivals try to stay ahead as Merck, Lilly chase
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
Flag link:
ASH: J&J's Darzalex cuts death risk by 40% in new myeloma patients
ASH: J&J's Darzalex cuts death risk by 40% in new myeloma patients
Fierce Pharma
JNJ
Darzalex
Multiple Myeloma
ASH2019
Flag link:
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
Flag link:
XBiotech out-licenses anti-inflammatory antibody to Janssen for up to $1.35B
XBiotech out-licenses anti-inflammatory antibody to Janssen for up to $1.35B
Seeking Alpha
Xbiotech
JNJ
Janssen
bermekimab
Flag link:
How 3D Printing Allows Medtech to‘Re-Imagine Innovation’
How 3D Printing Allows Medtech to‘Re-Imagine Innovation’
Medical Devices and Diagnostics Industry
JNJ
3D printing
devices
innovation
Flag link:
Six Drug Companies Subpoenaed In Federal Opioid Investigation
Six Drug Companies Subpoenaed In Federal Opioid Investigation
Forbes
opioids
opioid crisis
Teva Pharmaceutical
McKesson
Mallinckrodt
AmerisourceBergen
JNJ
Amneal
Flag link:

Pages